BPH Global Ltd (ASX:BP8)

Market Cap	4.71M +374.7%
Revenue (ttm)	1.73M +1,471.4%
Net Income	-2.13M
EPS	-0.00
Shares Out	2.35B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,267
Average Volume	11,964,458
Open	0.0020
Previous Close	0.0020
Day's Range	0.0020 - 0.0020
52-Week Range	0.0010 - 0.0050
Beta	0.57
RSI	49.35
Earnings Date	Feb 26, 2026

About BPH Global

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. BPH Global Ltd was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. The co...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1984
• Employees: 31
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BP8

Financial Performance

In fiscal year 2025, BPH Global's revenue was 352,376, an increase of 220.44% compared to the previous year's 109,965. Losses were -1.49 million, -43.94% less than in 2024.